News
JMP Securities Reiterates Market Outperform on Savara, Maintains $8 Price Target
19 Apr 24
News, Price Target, Reiteration, Analyst Ratings
JMP Securities Reiterates Market Outperform on Savara, Maintains $8 Price Target
18 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Savara To Present New Data On Autoimmune Pulmonary Alveolar Proteinosis At The American Thoracic Society International Conference 2024
8 Apr 24
Biotech, News, General
HC Wainwright & Co. Reiterates Buy on Savara, Maintains $6 Price Target
11 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Savara Q4 EPS $(0.09) Beats $(0.10) Estimate
7 Mar 24
Earnings, News
Piper Sandler Maintains Overweight on Savara, Raises Price Target to $16
4 Mar 24
News, Price Target, Analyst Ratings
On Feb 13, Savara Inc Entered Agreement With Fujifilm, Pursuant To Which Fujifilm Will Continue To Provide Development And Manufacturing Services Related To Active Pharmaceutical Ingredient For The Co's Molgramostim Product Candidate
16 Feb 24
News
JMP Securities Initiates Coverage On Savara with Market Outperform Rating, Announces Price Target of $8
15 Feb 24
News, Price Target, Initiation, Analyst Ratings
Press releases
Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024
8 Apr 24
Press Releases
Savara Announces New Employment Inducement Grant
22 Mar 24
Press Releases
Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
7 Mar 24
Press Releases
Savara Announces New Employment Inducement Grant
2 Feb 24
Press Releases
Savara to Present at Two Upcoming Healthcare Conferences
31 Jan 24
Press Releases